Market sentiment got a boost after U.S. biotech firm Moderna Inc's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in an ongoing early-stage study.Hopes were high among investors heading into a EU summit later this week that leaders will agree on a recovery fund of 750 billion euros for pandemic-hammered economies.